Modification of Epidermal Growth Factor-like Repeats Witho-Fucose
Yang Wang,Li Shao,Shaolin Shi,Reed J. Harris,Michael W. Spellman,Pamela Stanley,Robert S. Haltiwanger
DOI: https://doi.org/10.1074/jbc.m107849200
IF: 5.485
2001-01-01
Journal of Biological Chemistry
Abstract:The O-fucose modification is found on epidermal growth factor-like repeats of a number of cell surface and secreted proteins. O-Fucose glycans play important roles in ligand-induced receptor signaling. For example, elongation of O-fucose on Notch by the β1,3-N-acetylglucosaminyltransferase Fringe modulates the ability of Notch to respond to its ligands. The enzyme that addsO-fucose to epidermal growth factor-like repeats, GDP-fucose protein O-fucosyltransferase (O-FucT-1), was purified previously from Chinese hamster ovary (CHO) cells. Here we report the isolation of a cDNA that encodes human O-FucT-1. A probe deduced from N-terminal sequence analysis of purified CHOO-FucT-1 was used to screen a human heart cDNA library and expressed sequence tag and genomic data bases. The cDNA contains an open reading frame encoding a protein of 388 amino acids with a predicted N-terminal transmembrane sequence typical of a type II membrane orientation. Likewise, the mouse homolog obtained from an expressed sequence tag and 5′-rapid amplification of cDNA ends of a mouse liver cDNA library encodes a type II transmembrane protein of 393 amino acids with 90.4% identity to humanO-FucT-1. Homologs were also found inDrosophila and Caenorhabditis elegans with 41.2 and 29.4% identity to human O-FucT-1, respectively. The human gene (POFUT1) is on chromosome 20 betweenPLAGL2 and KIF3B, near the centromere at 20p11. The mouse gene (Pofut1) maps near Plagl2 on a homologous region of mouse chromosome 2. POFUT1 gene transcripts were expressed in all tissues examined, consistent with the widespread localization of the modification. Expression of a soluble form of human O-FucT-1 in insect cells yielded a protein of the predicted molecular weight with O-FucT-1 kinetic and enzymatic properties similar to those of O-FucT-1 purified from CHO cells. The identification of the gene encoding proteinO-fucosyltransferase I now makes possible mutational strategies to examine the functions of the unusual O-fucose post-translational modification. The O-fucose modification is found on epidermal growth factor-like repeats of a number of cell surface and secreted proteins. O-Fucose glycans play important roles in ligand-induced receptor signaling. For example, elongation of O-fucose on Notch by the β1,3-N-acetylglucosaminyltransferase Fringe modulates the ability of Notch to respond to its ligands. The enzyme that addsO-fucose to epidermal growth factor-like repeats, GDP-fucose protein O-fucosyltransferase (O-FucT-1), was purified previously from Chinese hamster ovary (CHO) cells. Here we report the isolation of a cDNA that encodes human O-FucT-1. A probe deduced from N-terminal sequence analysis of purified CHOO-FucT-1 was used to screen a human heart cDNA library and expressed sequence tag and genomic data bases. The cDNA contains an open reading frame encoding a protein of 388 amino acids with a predicted N-terminal transmembrane sequence typical of a type II membrane orientation. Likewise, the mouse homolog obtained from an expressed sequence tag and 5′-rapid amplification of cDNA ends of a mouse liver cDNA library encodes a type II transmembrane protein of 393 amino acids with 90.4% identity to humanO-FucT-1. Homologs were also found inDrosophila and Caenorhabditis elegans with 41.2 and 29.4% identity to human O-FucT-1, respectively. The human gene (POFUT1) is on chromosome 20 betweenPLAGL2 and KIF3B, near the centromere at 20p11. The mouse gene (Pofut1) maps near Plagl2 on a homologous region of mouse chromosome 2. POFUT1 gene transcripts were expressed in all tissues examined, consistent with the widespread localization of the modification. Expression of a soluble form of human O-FucT-1 in insect cells yielded a protein of the predicted molecular weight with O-FucT-1 kinetic and enzymatic properties similar to those of O-FucT-1 purified from CHO cells. The identification of the gene encoding proteinO-fucosyltransferase I now makes possible mutational strategies to examine the functions of the unusual O-fucose post-translational modification. epidermal growth factor-like urinary-type plasminogen activator protein O-fucosyltransferase 1 Chinese hamster ovary polymerase chain reaction kilobase(s) expressed sequence tag nickel-nitrilotriacetic acid high performance liquid chromatography thrombospondin type 1 repeat The extent and variety of carbohydrate modifications found on proteins are enormous. Although historically a major focus has been on determining the structure and function of N-glycans attached to asparagine residues, our knowledge of the scope and variety of serine/threonine-linked O-glycans has expanded greatly in the last decade. In addition to the well known mucin-typeO-GalNAc and glycosaminoglycan O-xylose classes of glycans, several others have been described, includingO-GlcNAc modification of nuclear and cytoplasmic proteins (1Comer F.I. Hart G.W. J. Biol. Chem. 2000; 275: 29179-29182Abstract Full Text Full Text PDF PubMed Scopus (328) Google Scholar), O-mannose modification of brain glycoproteins (2Smalheiser N.R. Haslam S.M. Sutton-Smith M. Morris H.R. Dell A. J. Biol. Chem. 1998; 273: 23698-23703Abstract Full Text Full Text PDF PubMed Scopus (118) Google Scholar), andO-glucose and O-fucose modifications of epidermal growth factor-like (EGF)1repeats (3Harris R.J. Spellman M.W. Glycobiology. 1993; 3: 219-224Crossref PubMed Scopus (222) Google Scholar). Several recent publications demonstrate that these novel forms of protein O-glycosylation play interesting and significant roles in the biological functions of the proteins they modify (4Shafi R. Iyer S.P. Ellies L.G. O'Donnell N. Marek K.W. Chui D. Hart G.W. Marth J.D. Proc. Natl. Acad. Sci. U. S. A. 2000; 97: 5735-5739Crossref PubMed Scopus (605) Google Scholar, 5Moloney D.J. Panin V.M. Johnston S.H. Chen J. Shao L. Wilson R. Wang Y. Stanley P. Irvine K.D. Haltiwanger R.S. Vogt T.F. Nature. 2000; 406: 369-375Crossref PubMed Scopus (723) Google Scholar). Fucose in O-linkage to serine or threonine was originally identified in amino acid fucosides isolated from human urine (6Hallgren P. Lundblad A. Svensson S. J. Biol. Chem. 1975; 250: 5312-5314Abstract Full Text PDF PubMed Google Scholar). The first protein reported to bear an O-fucose modification on an EGF repeat was urinary-type plasminogen activator (uPA) (7Kentzer E.J. Buko A.M. Menon G. Sarin V.K. Biochem. Biophys. Res. Commun. 1990; 171: 401-406Crossref PubMed Scopus (73) Google Scholar). Several other proteins were subsequently found to have O-fucose modifications, and comparison of the sequences surrounding modified serines or threonines led to the proposal of a consensus sequence forO-fucose modification: C2 XXGGS/TC3, where C2 and C3 are the second and third conserved cysteine residues of the EGF repeat, X is any amino acid, and S/T is the modified serine or threonine (3Harris R.J. Spellman M.W. Glycobiology. 1993; 3: 219-224Crossref PubMed Scopus (222) Google Scholar). Many proteins containing this sequence in the context of an EGF repeat have been identified in data base searches, and several of these proteins have subsequently been demonstrated to contain O-fucose residues (8Harris R.J. Van Halbeek H. Glushka J. Basa L.J. Ling V.T. Smith K.J. Spellman M.W. Biochemistry. 1993; 32: 6539-6547Crossref PubMed Scopus (96) Google Scholar, 9Moloney D.J. Haltiwanger R.S. Glycobiology. 1999; 9: 679-687Crossref PubMed Scopus (44) Google Scholar, 10Moloney D.J. Shair L. Lu F.M. Xia J. Locke R. Matta K.L. Haltiwanger R.S. J. Biol. Chem. 2000; 275: 9604-9611Abstract Full Text Full Text PDF PubMed Scopus (291) Google Scholar). O-Fucose glycans exist on glycoproteins as either a monosaccharide (Fuc-O-Ser/Thr), a tetrasaccharide (NeuAcα2, 3/6Galβ1, 4GlcNAcβ1, 3Fuc-O-Ser/Thr), or a di- or trisaccharide intermediate in tetrasaccharide biosynthesis (3Harris R.J. Spellman M.W. Glycobiology. 1993; 3: 219-224Crossref PubMed Scopus (222) Google Scholar, 5Moloney D.J. Panin V.M. Johnston S.H. Chen J. Shao L. Wilson R. Wang Y. Stanley P. Irvine K.D. Haltiwanger R.S. Vogt T.F. Nature. 2000; 406: 369-375Crossref PubMed Scopus (723) Google Scholar). Recent work from several laboratories has demonstrated a functional role for O-fucose glycans on the Notch protein. Fringe, a modulator of Notch signaling (11Irvine K.D. Curr. Opin. Genet. Dev. 1999; 9: 434-441Crossref PubMed Scopus (168) Google Scholar), is an O-fucose β1,3-N-acetylglucosaminyltransferase that extends theO-fucose moieties on Notch (5Moloney D.J. Panin V.M. Johnston S.H. Chen J. Shao L. Wilson R. Wang Y. Stanley P. Irvine K.D. Haltiwanger R.S. Vogt T.F. Nature. 2000; 406: 369-375Crossref PubMed Scopus (723) Google Scholar, 12Bruckner K. Perez L. Clausen H. Cohen S. Nature. 2000; 406: 411-415Crossref PubMed Scopus (597) Google Scholar). Elongation ofO-fucose residues on EGF repeats of Notch by Fringe modulates Notch activation by the ligands Delta and Serrate/Jagged. Fringe potentiates signaling from Delta but inhibits signaling from Serrate/Jagged (13Panin V.M. Papayannopoulos V. Wilson R. Irvine K.D. Nature. 1997; 387: 908-912Crossref PubMed Scopus (508) Google Scholar, 14Fleming R.J. Gu Y. Hukriede N.A. Development. 1997; 124: 2973-2981Crossref PubMed Google Scholar). How the elongation of O-fucose residues on Notch mediates altered signaling is not yet understood, but the β1,3-N-acetylglucosaminyltransferase activity is essential for Fringe to exert its effects on Notch (5Moloney D.J. Panin V.M. Johnston S.H. Chen J. Shao L. Wilson R. Wang Y. Stanley P. Irvine K.D. Haltiwanger R.S. Vogt T.F. Nature. 2000; 406: 369-375Crossref PubMed Scopus (723) Google Scholar, 12Bruckner K. Perez L. Clausen H. Cohen S. Nature. 2000; 406: 411-415Crossref PubMed Scopus (597) Google Scholar, 15Munro S. Freeman M. Curr. Biol. 2000; 10: 813-820Abstract Full Text Full Text PDF PubMed Scopus (165) Google Scholar). These results demonstrate that the O-fucose modification plays a key role in regulating an important signal transduction event: activation of the Notch receptor. Another signaling reaction influenced by O-fucose is that of uPA and its receptor (16Rabbani S.A. Mazar A.P. Bernier S.M. Haq M. Bolivar I. Henkin J. Goltzman D. J. Biol. Chem. 1992; 267: 14151-14156Abstract Full Text PDF PubMed Google Scholar). BecauseO-fucose exists on a number of other biologically important proteins, it may also influence their functions. The enzyme responsible for adding O-fucose to EGF repeats (GDP-fucose protein O-fucosyltransferase 1 orO-FucT-1) was originally identified and purified from Chinese hamster ovary (CHO) cells (17Wang Y. Lee G.F. Kelley R.F. Spellman M.W. Glycobiology. 1996; 6: 837-842Crossref PubMed Scopus (57) Google Scholar, 18Wang Y. Spellman M.W. J. Biol. Chem. 1998; 273: 8112-8118Abstract Full Text Full Text PDF PubMed Scopus (97) Google Scholar). Interestingly,O-FucT-1 does not fucosylate synthetic peptides containing the C2 XXGGS/TC3 consensus sequence, but it does require a properly folded EGF repeat with the consensus sequence as acceptor (18Wang Y. Spellman M.W. J. Biol. Chem. 1998; 273: 8112-8118Abstract Full Text Full Text PDF PubMed Scopus (97) Google Scholar). A significant fraction ofO-FucT-1 activity in CHO cells is soluble, but it appears to be a membrane-bound protein released by proteolysis as observed with many other Golgi glycosyltransferases (19Kleene R. Berger E.G. Biochim. Biophys. Acta Rev. Biomembr. 1993; 1154: 283-325Crossref PubMed Scopus (202) Google Scholar). As with most glycosyltransferases, O-FucT-1 is strongly activated by manganese. It was purified more than 5,000-fold using affinity chromatography on columns made with acceptor substrate (recombinant EGF repeat from factor VII) and donor substrate (GDP-hexanolamine-Sepharose) (18Wang Y. Spellman M.W. J. Biol. Chem. 1998; 273: 8112-8118Abstract Full Text Full Text PDF PubMed Scopus (97) Google Scholar). In this paper we present the N-terminal sequence for the CHO O-FucT-1 and its use in identifying a cDNA for human O-FucT-1. Transcripts of the gene (HGNC-approved symbol: POFUT1) are expressed in all human tissues examined, and homologous genes exist in mice, Drosophila, and Caenorhabditis elegans. These results are consistent with the widespread occurrence of theO-fucose modification on proteins. CHO O-FucT-1 was purified as described (18Wang Y. Spellman M.W. J. Biol. Chem. 1998; 273: 8112-8118Abstract Full Text Full Text PDF PubMed Scopus (97) Google Scholar), and 2 µg of purified enzyme was subjected to N-terminal peptide sequence analysis using a Hewlett-Packard model G1000A protein sequencer. Based on the peptide sequence of CHO O-FucT-1, a blast search was performed in GenBank (Unigene), and a human cDNA sequence, KIAA0180 (accession number D80002) was obtained which contains an open reading frame encoding a protein of 366 amino acids. PCR primers were designed based on sequences from KIAA0180: kiaa 16–55 (5′-CTTCTTGGGCTCTCTGGCATTTGCAAAGCTGCTAAACCGT-3′) and kiaa 1110–1071 (5′-GCCCTGGGATATGGAGCGTCTCCCTCCTTGAGGGGTCCCT-3′). Using a human heart cDNA library (CLONTECH) as template, a 1.1-kb PCR product was obtained. A radiolabeled probe was generated from the PCR product by random priming, and the probe was used to screen the human heart cDNA library according to the manufacturer's instructions. Recombinant λ DNA from purified positive clones was digested with EcoRI and subjected to Southern analysis. The probe for the Southern analysis was made from two partially overlapping oligonucleotides from the 5′-end of the KIAA0180 sequence (kiaa 16–55, see above, and kiaa 80–41, 5′-CAATCCAAGGAGGGACAGCCAAGGTACGGTTTAGCAGCTT-3′). The probe was filled in using Klenow fragment and 32P-labeled dNTPs.EcoRI fragments reacting with the probe were purified on agarose gels and subcloned into pBluescript II SK+ plasmid (Stratagene), and the resulting plasmids were sequenced. A clone containing the coding region of the POFUT1 gene was used for all subsequent experiments (pBS-hOFT). Additional 3′- and 5′-untranslated regions were determined by assembling overlappingPOFUT1 ESTs from dbEST and from the human genomic DNA sequence (accession number AL121897). To obtain the mouse sequence, KIAA0180 was used to search the mouse EST data base, and one EST (accession number AI664300, 460 base pairs) was found. To obtain 5′ sequence two primers (PS513, 5′-CCGTCCTCACCATCTCATCTGA-3′; and PS511, 5′-ACATGTCTTCTTATCAGGACTTCG-3′) based on this EST were used with Marathon-ready cDNA (CLONTECH) from mouse liver. From a 0.5-kb 5′-rapid amplification of cDNA ends product and the EST a 760-base pair sequence was obtained. The 3′-region was derived from mouse genomic DNA sequence (accession number AC078911) and was confirmed by reverse transcription-PCR using primers, PS598 (5′-GGGACCAGTTTCATGTGAGTTTCAATAAGTCAGA-3′) and PS599 (5′-CCACCTCTGGCAGAAAAGAAAAGGGATGTGTAAT-3′) with Marathon-ready cDNA from liver (CLONTECH) as the template. The POFUT1 coding sequence was excised from pBS-hOFT using EcoRI and labeled by random priming using the Ready-to-Go kit from Amersham Pharmacia Biotech according to the manufacturer's instructions to a specific activity of 1 × 109 cpm/µg. A human multitissue RNA blot was purchased from CLONTECH, probed, and washed under high stringency conditions according to the manufacturer's instruction for cDNA probes. Baculovirus-mediated insect cell expression was used to express a soluble form of human O-FucT-1 (amino acids 24–388) with an N-terminal His6 tag. A baculovirus transfer vector with a signal peptide was generated from pVL1392HAX (20Ruppert S. Wang E.H. Tjian R. Nature. 1993; 362: 175-179Crossref PubMed Scopus (192) Google Scholar). Two complementary oligonucleotides (RS1, 5′-CATGGCCAAGTTCCTGGTCAACGTGGCCCTGCTGCTGCTGCTGCTGCTGCTGTCCGGAGCCTGGGCCCA-3′; and RS2, 5′-TATGGGCCCAGGCTCCGGACAGCAGCAGCAGCAGCAGCAGCAGGGCCACGTTGACCAGGAACTTGGC-3′) encoding the signal sequence from honeybee melittin were generated and subcloned into the NcoI/NdeI site of pVL1392HAX. The resulting transfer vector was called pbSP. The coding sequence for the luminal domain of human POFUT1 was excised from pBS-hOFT using SacII and XbaI. Two complementary oligonucleotides (YW1, 5′-TGGGCCCATATGAGATCCCATCACCATCACCATCACATGCCCGCGGGCTCC-3′; and YW2, 5′-GGAGCCCGCGGGCATGTGATGGTGATGGTGATGGGATCTCATATGGGCCCA-3′) encoding NdeI and SacII sites and the His6 sequence was used as linker for the cDNA and vector. The baculovirus transfer vector (pbSP) was cut withNdeI and SpeI (compatible with XbaI). A triple ligation was performed with pbSP, the excised cDNA, and the His6-encoding linker, and the resulting plasmid was transfected into Sf9 cells using the BaculoGold expression kit (Pharmingen). Recombinant viral clones were plaque purified three times. Viral stocks of 108 plaque-forming units/ml were prepared by repeated amplification. The protein was expressed by infecting 2 × 107 Sf9 cells with 5 × 108 plaque-forming units of recombinant virus. Medium was collected 72 h after infection, clarified by centrifugation, dialyzed against 20 mm Tris-HCl, pH 8.0, and loaded onto a 0.5-ml Ni2+-NTA-agarose column (Qiagen). The column was washed with 4 ml of 0.1 m Tris-HCl, pH 8.0, 0.5m NaCl and eluted sequentially with 2 ml of 25 mm imidazole HCl, pH 7.0, 0.5 m NaCl followed by 3 ml of 0.5 m imidazole HCl, pH 7.0. Each fraction was subjected to SDS-polyacrylamide gel electrophoresis, stained with silver and assayed for enzyme activity. O-FucT-1 activity was assayed using GDP-[3H]fucose and recombinant His6-tagged factor VII EGF domain as described (17Wang Y. Lee G.F. Kelley R.F. Spellman M.W. Glycobiology. 1996; 6: 837-842Crossref PubMed Scopus (57) Google Scholar). All assays were performed as duplicates. N-terminal sequence analysis was performed on the purified protein as described above. Product analysis (reverse phase HPLC, β-elimination ofO-linked sugars, gel filtration using a Superdex column, and high pH anion exchange chromatographic analysis on a Dionex MA1 column) of fucosylated EGF repeat was performed as described (10Moloney D.J. Shair L. Lu F.M. Xia J. Locke R. Matta K.L. Haltiwanger R.S. J. Biol. Chem. 2000; 275: 9604-9611Abstract Full Text Full Text PDF PubMed Scopus (291) Google Scholar). O-FucT-1 was purified from CHO cells as described (18Wang Y. Spellman M.W. J. Biol. Chem. 1998; 273: 8112-8118Abstract Full Text Full Text PDF PubMed Scopus (97) Google Scholar) and subjected to N-terminal sequencing. The N-terminal peptide sequence of 61 amino acids was obtained: RLAGSWDLAGYLLYXPXMGRFGNQADHFLGSLAFAKLXVRTLAVPPWIEYQHHKPPFTNLH, where cycles that yielded uncertain residues are marked asX. Blast searches with the sequence above revealed a cDNA, KIAA0180 (accession number D80002), coding for a 366-amino acid protein of unknown function from the human myeloblast cell line KG-1. Mammalian glycosyltransferases are typically type II transmembrane proteins (19Kleene R. Berger E.G. Biochim. Biophys. Acta Rev. Biomembr. 1993; 1154: 283-325Crossref PubMed Scopus (202) Google Scholar, 21Paulson J.C. Colley K.J. J. Biol. Chem. 1989; 264: 17615-17618Abstract Full Text PDF PubMed Google Scholar), but computer analysis failed to find a transmembrane domain near the N terminus of the predicted human protein. To obtain a clone with a complete open reading frame, a human heart cDNA library was screened. Initially, a PCR fragment was obtained from the library using kiaa 16–55 and kiaa 1110–1071 as primers, and a probe was made from the PCR fragment using the random priming method. The human heart cDNA library was screened using this probe, and a number of clones were identified. DNA sequencing confirmed that they contained the KIAA0180 sequence with varying 5′-extensions. One clone extended the open reading frame upstream to an “ATG” that results in a protein with a classic type II transmembrane domain (accession number for cDNA AF375884). This 5′-sequence is present in the human genomic DNA sequence (accession number AL121897). Additional cDNA sequence including 3′- and 5′-untranslated regions were determined by assembling overlappingPOFUT1 ESTs from dbEST and from the human genome sequence. The human POFUT1 cDNA encodes a protein of 388 amino acids with a predicted type II transmembrane organization (Fig.1, accession number AF375884). The N-terminal sequence obtained from CHO O-FucT-1 begins at the end of the predicted transmembrane domain, suggesting that during purification, CHO O-FucT-1 was proteolyzed, as is typical of many glycosyltransferases, and consistent with the solubility properties of CHO O-FucT-1 (17Wang Y. Lee G.F. Kelley R.F. Spellman M.W. Glycobiology. 1996; 6: 837-842Crossref PubMed Scopus (57) Google Scholar, 18Wang Y. Spellman M.W. J. Biol. Chem. 1998; 273: 8112-8118Abstract Full Text Full Text PDF PubMed Scopus (97) Google Scholar). The cDNA also contains an extensive 3′-untranslated region, typical of many glycosyltransferases (22Breton C. Imberty A. Curr. Opin. Struct. Biol. 1999; 9: 563-571Crossref PubMed Scopus (171) Google Scholar). Two potential polyadenylation signals were found, providing an explanation for the existence of a doublet by Northern analysis (see below). To obtain a mouse POFUT1 cDNA sequence, KIAA0180 was used to search the mouse EST data base, and one EST (accession numberAI664300, 460 base pairs) was found. Two primers based on this EST sequence, PS513 and PS511, were used to amplify the 5′-region with Marathon-ready cDNA from mouse liver. By assembling the 0.5-kb PCR product and the EST, a 760-base pair sequence that encodes the N-terminal region of a protein with a typical type II transmembrane domain was obtained. The remaining 3′-coding sequence of mousePOFUT1 was derived from mouse genomic DNA sequence (accession number AC078911) and was confirmed by PCR using PS598 and PS599 with Marathon-ready cDNA from mouse liver. 15 nucleotide discrepancies between the cDNA sequence and the genomic DNA sequence included 7 that give amino acid changes. All 7 amino acid residues in the mouse cDNA are identical to the equivalent residue in the human POFUT1 sequence. The mouse POFUT1cDNA encodes a protein of 393 amino acids with a type II transmembrane domain (accession number AF375885). The full-length amino acid sequence of human O-FucT-1 was used to search the Drosophila and C. elegans data bases, and a related gene is present in both organisms (accession number AAF58290.1 for Drosophila and T15511 for C. elegans). The C. elegans POFUT1 gene includes 109 extra amino acids at the N terminus, which derives from three 5′-exons predicted by computer algorithm. These 109 amino acids represent an unusually long cytoplasmic domain for a glycosyltransferase and may or may not be present in the C. elegans O-FucT-1. NoPOFUT1 gene homologs were found in yeast or prokaryotes. Human and mouse O-FucT-1 are both type II transmembrane proteins and share a high level of identity (90.4%) (Fig.2), whereas the Drosophila andC. elegans homologs show 41.2 and 29.4% identity with humanO-FucT-1, respectively. Six cysteines and one potentialN-glycan consensus site are conserved, as well as the majority of aromatic residues. The CHO O-FucT-1 is known to be N-glycosylated (18Wang Y. Spellman M.W. J. Biol. Chem. 1998; 273: 8112-8118Abstract Full Text Full Text PDF PubMed Scopus (97) Google Scholar), suggesting that valine in the CHO sequence at the predicted N-glycosylation site (Fig. 2) is probably the result of a sequencing error. A conserved DXD-like motif (ERD, see Fig. 2), found in many classes of glycosyltransferase (23Wiggins C.A.R. Munro S. Proc. Natl. Acad. Sci. U. S. A. 1998; 95: 7945-7950Crossref PubMed Scopus (321) Google Scholar), is located near the C terminus. Comparison of the humanPOFUT1 cDNA coding sequence with the genomic DNA sequence (accession number AL121897) revealed that humanPOFUT1 is organized into 7 exons (Fig.3A). The boundary sequences of the six exon/intron junctions are shown in Fig. 3 B. Previous analysis of the KIAA0180 sequence mapped it to human chromosome 20 ((24Kikuno R. Nagase T. Suyama M. Waki M. Hirosawa M. Ohara O. Nucleic Acids Res. 2000; 28: 331-332Crossref PubMed Scopus (42) Google Scholar), www.kazusa.or.jp/huge/gfpage/KIAA0180/), and analysis of the BAC clone RP11-392M18 (accession number AL121897) shows thatPOFUT1 lies between PLAGL2 and KIF3B, close to the centromere of chromosome 20 at 20q11. The mousePofut1 gene has the same exon/intron organization as the human gene (data not shown), whereas the Drosophila andC. elegans Pofut1-related genes are organized differently (data not shown). Analysis of the BAC clone RP23-111A22 (accession number AC078911) from mouse chromosome 2 reveals thatPofut1 lies adjacent to Plagl2 in a region homologous with human chromosome 20. The mouse BAC clone terminates before the Kif3B gene predicted to followPofut1. Northern analysis showed major transcripts from the POFUT1 gene of ∼5 kb expressed at high levels in all human tissues examined (Fig.4). Several other weaker bands also hybridized, suggesting that there may be other transcripts expressed in some tissues. Previous analysis of the expression pattern of KIAA0180 ((22), www.kazusa.or.jp/huge/gfpage/KIAA0180/) showed a similar pattern of expression in spleen, thymus, prostate, testis, ovary, small intestine, colon, and peripheral blood leukocytes. They also showed resolution of the major transcripts into two species of ∼4.8 and 5.4 kb, consistent with the sizes predicted from the cDNA sequence using the two polyadenylation signals identified in the 3′-untranslated region (Fig. 1). To demonstrate that the cloned POFUT1 cDNA encodes a protein withO-FucT-1 activity, a partial POFUT1 cDNA encoding the predicted O-FucT-1 luminal domain (amino acids 24–388, lacking the transmembrane domain) was cloned into a baculoviral expression plasmid containing an N-terminal signal sequence and His6 tag for expression in insect cells (Fig.5A). Sf9 cells were infected with recombinant virus, and the His6-tagged humanO-FucT-1 was purified from the medium using Ni2+-NTA-agarose. Fractions from the purification were analyzed by SDS-polyacrylamide gel electrophoresis (Fig. 5 B) and for O-FucT-1 enzymatic activity (Fig. 5 C). The activity bound to the Ni2+-NTA-agarose column and eluted with imidazole. A 43-kDa protein coeluted with the activity (Fig. 5 B), in agreement with the predicted size of truncatedO-FucT-1. Amino terminal sequence analysis of the purified protein gave:XXRSHHHHHHMPAGSWDPAGYLLYXPXMGR, confirming that the expressed protein was the His6-tagged recombinant human O-FucT-1. Product characterization demonstrated that the secretedO-fucosyltransferase generated the correct product. Reverse phase HPLC analysis of 3H-fucosylated product showed that the radioactivity migrated exclusively with the factor VII EGF repeat (Fig. 6A), demonstrating that the [3H]fucose was covalently associated with the EGF repeat. The [3H]fucose was released from the EGF repeat by alkali-induced β-elimination forming the monosaccharide [3H]fucitol (Fig. 6, B and C), the expected product from the β-elimination of O-fucose in the presence of sodium borohydride. These results demonstrate that recombinant O-FucT-1 adds O-fucose to factor VII EGF repeat. To compare recombinant human O-FucT-1 with the purified CHO O-FucT-1 further, the dependence of activity on protein and substrate concentrations was examined (Fig.7). The kinetic parameters of human O-FucT-1 for the substrates factor VII EGF repeat and GDP-fucose compare favorably with the published values for purified CHOO-FucT-1. The Km obtained for factor VII EGF was 6 µm compared with 11 µm for CHO O-FucT-1 (18Wang Y. Spellman M.W. J. Biol. Chem. 1998; 273: 8112-8118Abstract Full Text Full Text PDF PubMed Scopus (97) Google Scholar), and for GDP-fucose, theKm was 4 µm compared with 5.9–6.4 µm for CHO O-FucT-1 (18Wang Y. Spellman M.W. J. Biol. Chem. 1998; 273: 8112-8118Abstract Full Text Full Text PDF PubMed Scopus (97) Google Scholar). TheV max for recombinant human O-FucT-1 was 3 µmol/min·mg compared with 2.5 µmol/min·mg for CHOO-FucT-1 (18Wang Y. Spellman M.W. J. Biol. Chem. 1998; 273: 8112-8118Abstract Full Text Full Text PDF PubMed Scopus (97) Google Scholar). As noted for purified CHO O-FucT-1 (18Wang Y. Spellman M.W. J. Biol. Chem. 1998; 273: 8112-8118Abstract Full Text Full Text PDF PubMed Scopus (97) Google Scholar), high concentrations of EGF repeat caused inhibition of fucose transfer by human O-FucT-1 (data not shown). In addition, human O-FucT-1 was inhibited by EDTA (data not shown), consistent with the manganese requirement of CHO O-FucT-1 activity (18Wang Y. Spellman M.W. J. Biol. Chem. 1998; 273: 8112-8118Abstract Full Text Full Text PDF PubMed Scopus (97) Google Scholar). These results demonstrate that the clonedPOFUT1 cDNA encodes the O-FucT-1 glycosyltransferase. The O-fucose modification has been found on proteins from a wide variety of species, ranging from humans to fruit flies (3Harris R.J. Spellman M.W. Glycobiology. 1993; 3: 219-224Crossref PubMed Scopus (222) Google Scholar,5Moloney D.J. Panin V.M. Johnston S.H. Chen J. Shao L. Wilson R. Wang Y. Stanley P. Irvine K.D. Haltiwanger R.S. Vogt T.F. Nature. 2000; 406: 369-375Crossref PubMed Scopus (723) Google Scholar), and a protein O-fucosyltransferase that generates the modification has been purified from CHO cells (18Wang Y. Spellman M.W. J. Biol. Chem. 1998; 273: 8112-8118Abstract Full Text Full Text PDF PubMed Scopus (97) Google Scholar). In this paper we report the sequences of human and mouse cDNAs that encodeO-FucT-1 and the organization of the human POFUT1gene. The POFUT1 gene sequence is highly conserved in mammals and is also present in Drosophila and C. elegans. The gene is expressed in all mammalian tissues examined, suggesting that the O-fucose modification may play biological roles in different contexts. O-FucT-1 has a predicted type II transmembrane structure, consistent with the domain organization of nearly all known mammalian Golgi glycosyltransferases (19Kleene R. Berger E.G. Biochim. Biophys. Acta Rev. Biomembr. 1993; 1154: 283-325Crossref PubMed Scopus (202) Google Scholar, 21Paulson J.C. Colley K.J. J. Biol. Chem. 1989; 264: 17615-17618Abstract Full Text PDF PubMed Google Scholar) and the membrane association data of the enzyme (17Wang Y. Lee G.F. Kelley R.F. Spellman M.W. Glycobiology. 1996; 6: 837-842Crossref PubMed Scopus (57) Google Scholar).O-FucT-1 does not share any obvious sequence similarity with any other class of glycosyltransferases, including the α1,2, α1,3/4, or α1,6-fucosyltransferases (22Breton C. Imberty A. Curr. Opin. Struct. Biol. 1999; 9: 563-571Crossref PubMed Scopus (171) Google Scholar). Six highly conserved cysteines are present in O-FucT-1 as well as a DXD-like motif (ERD), conserved in mammals,Drosophila, and C. elegans. Both features are characteristic of several glycosyltransferase families (22Breton C. Imberty A. Curr. Opin. Struct. Biol. 1999; 9: 563-571Crossref PubMed Scopus (171) Google Scholar, 23Wiggins C.A.R. Munro S. Proc. Natl. Acad. Sci. U. S. A. 1998; 95: 7945-7950Crossref PubMed Scopus (321) Google Scholar). Only one homologous gene has been identified for each species. The presence of O-fucose on EGF repeats is known to play a critical role in signal transduction through two distinct pathways. Binding of uPA to the uPA receptor is mediated through the EGF repeat of uPA (16Rabbani S.A. Mazar A.P. Bernier S.M. Haq M. Bolivar I. Henkin J. Goltzman D. J. Biol. Chem. 1992; 267: 14151-14156Abstract Full Text PDF PubMed Google Scholar, 25Appella E. Robinson E.A. Ullrich S.J. Stoppelli M.P. Corti A. Cassini G. Blasi F. J. Biol. Chem. 1987; 262: 4437-4440Abstract Full Text PDF PubMed Google Scholar). Removal of O-fucose from the EGF repeat has no effect on binding to the uPA receptor, but bound, unfucosylated EGF repeat does not activate the receptor. Thus, the O-fucose modification is not required for binding, but it plays an essential role in activation of the uPA receptor. The details of howO-fucose mediates this effect are not understood, but it is known that the addition of O-fucose to an EGF repeat does not significantly alter the conformation of the polypeptide chain. Using NMR, Kao and co-workers (26Kao Y.-H. Lee G.F. Wang Y. Starovasnik M.A. Kelley R.F. Spellman M.W. Lerner L. Biochemistry. 1999; 38: 7097-7110Crossref PubMed Scopus (36) Google Scholar) examined the structure of the factor VII EGF repeat with and without an O-fucose. The presence of the O-fucose had very little effect on the tertiary structure of the EGF repeat, but it did form a significant knob-like feature on one face of the module. Thus, modification of the protein with O-fucose would not be predicted to cause a conformational change in the protein, but it could certainly affect the interactions of the EGF repeat with other molecules. In the Notch signaling pathway, O-fucose also plays a key role in receptor activation. O-Fucose serves as an acceptor for Fringe, a β1,3-N-acetylglucosaminyltransferase, resulting in the elongation of the O-fucose monosaccharide into a tetrasaccharide on EGF repeats of Notch (5Moloney D.J. Panin V.M. Johnston S.H. Chen J. Shao L. Wilson R. Wang Y. Stanley P. Irvine K.D. Haltiwanger R.S. Vogt T.F. Nature. 2000; 406: 369-375Crossref PubMed Scopus (723) Google Scholar, 12Bruckner K. Perez L. Clausen H. Cohen S. Nature. 2000; 406: 411-415Crossref PubMed Scopus (597) Google Scholar). This alteration in the carbohydrate structure somehow modulates receptor activation. Interestingly, the activation of Notch can be either potentiated or inhibited, depending on the ligand (13Panin V.M. Papayannopoulos V. Wilson R. Irvine K.D. Nature. 1997; 387: 908-912Crossref PubMed Scopus (508) Google Scholar, 14Fleming R.J. Gu Y. Hukriede N.A. Development. 1997; 124: 2973-2981Crossref PubMed Google Scholar). Again, it is unlikely that the change in sugar structure alters the conformation of the individual EGF repeat, but such a change could certainly affect the ability of the modified EGF repeat to interact with ligands, other proteins, or even other portions of the Notch protein itself. Recently the presence of O-fucose in a different protein context was reported (27Hofsteenge J. Huwiler K.G. Macek B. Hess D. Lawler J. Mosher D.F. Peter-Katalinic J. J. Biol. Chem. 2001; 276: 6485-6498Abstract Full Text Full Text PDF PubMed Scopus (211) Google Scholar). Hofsteenge and co-workers showed the presence of the disaccharide Glc-Fuc O-linked to serines and threonines within the three thrombospondin type 1 repeats (TSR) of human thrombospondin-1. By comparing the sequence contexts surrounding the modified residues in each TSR they proposed the consensus sequence, CSX S/TCG, where S/T is the modified residue. AnO-linked Glcβ1,3Fuc modification of proteins in CHO cells has also been described (28Moloney D.J. Lin A.I. Haltiwanger R.S. J. Biol. Chem. 1997; 272: 19046-19050Abstract Full Text Full Text PDF PubMed Scopus (50) Google Scholar), although CHO proteins with this modification were not identified. The results of Hofsteenge and co-workers suggest that two separate O-fucose pathways exist: one modifying EGF repeats, and the other modifying TSRs. Elongation of O-fucose occurs in both pathways, but the elongation does not appear to overlap. O-Fucose on EGF repeats can be modified by a β1,3-linked GlcNAc, catalyzed by Fringe (5Moloney D.J. Panin V.M. Johnston S.H. Chen J. Shao L. Wilson R. Wang Y. Stanley P. Irvine K.D. Haltiwanger R.S. Vogt T.F. Nature. 2000; 406: 369-375Crossref PubMed Scopus (723) Google Scholar, 12Bruckner K. Perez L. Clausen H. Cohen S. Nature. 2000; 406: 411-415Crossref PubMed Scopus (597) Google Scholar), whereas O-fucose on TSRs appears to be elongated by a β1,3-linked Glc (27Hofsteenge J. Huwiler K.G. Macek B. Hess D. Lawler J. Mosher D.F. Peter-Katalinic J. J. Biol. Chem. 2001; 276: 6485-6498Abstract Full Text Full Text PDF PubMed Scopus (211) Google Scholar). An enzymatic activity capable of addition of Glc in a β1,3-linkage to fucose has been described (9Moloney D.J. Haltiwanger R.S. Glycobiology. 1999; 9: 679-687Crossref PubMed Scopus (44) Google Scholar). Interestingly, the β1,3-glucosyltransferase would not useO-fucose attached to an EGF repeat as a substrate under various conditions tested, 2D. J. Moloney and R. S. Haltiwanger, unpublished observation.suggesting that the addition of the Glc to fucose occurs only when the fucose is in a particular protein context such as a TSR. The region of thrombospondin-1 modified with the Glc-Fuc disaccharide binds to heparin and appears to be involved in a number of biologically important interactions (29Adams J.C. Tucker R.P. Dev. Dyn. 2000; 218: 280-299Crossref PubMed Scopus (265) Google Scholar), raising the interesting possibility that this class of O-fucose modifications may modulate biological events in a manner similar to O-fucose on the Notch receptor. The importance of fucose modifications on proteins has been highlighted recently by the description of the disease leukocyte adhesion deficiency type II (30Becker D.J. Lowe J.B. Biochim. Biophys. Acta. 1999; 1455: 193-204Crossref PubMed Scopus (94) Google Scholar). Patients with this disorder have reduced levels of fucose on proteins. The underfucosylation is caused by defects in the GDP-fucose transporter resulting in inefficient transport of GDP-fucose into the Golgi apparatus (31Lubke T. Marquardt T. von Figura K. Korner C. J. Biol. Chem. 1999; 274: 25986-25989Abstract Full Text Full Text PDF PubMed Scopus (119) Google Scholar, 32Luhn K. Wild M.K. Eckhardt M. Gerardy-Schahn R. Vestweber D. Nat. Genet. 2001; 28: 69-72Crossref PubMed Scopus (289) Google Scholar). The patients suffer from a wide variety of developmental and pathological problems (30Becker D.J. Lowe J.B. Biochim. Biophys. Acta. 1999; 1455: 193-204Crossref PubMed Scopus (94) Google Scholar). As the name of the disorder implies, they have a defect in recruitment of leukocytes to sites of inflammation, resulting in severe recurring bacterial infections. Leukocytes are recruited to sites of inflammation by recognition of specific fucose-containing oligosaccharide structures on their surfaces, and reduced levels of fucose impair efficient recruitment (33McEver R.P. Glycoconjugate J. 1997; 14: 585-591Crossref PubMed Scopus (240) Google Scholar). In addition to recurrent infections, these patients suffer from developmental abnormalities. They are short in stature, have unusual facial and skeletal abnormalities, and are severely mentally retarded. Because Notch receptors play key roles in numerous developmental events (34Artavanis-Tsakonas S. Rand M.D. Lake R.J. Science. 1999; 284: 770-776Crossref PubMed Scopus (4951) Google Scholar), it may be that several of the other features of leukocyte adhesion deficiency type II can be explained by defects in Notch function.
What problem does this paper attempt to address?
-
Chemoenzymatic Probes for Detecting and Imaging Fucose-Α(1-2)-galactose Glycan Biomarkers.
Jean-Luc Chaubard,Chithra Krishnamurthy,Wen Yi,David Smith,Linda Hsieh-Wilson
DOI: https://doi.org/10.1021/ja211312u
2012-01-01
Abstract:The disaccharide motif fucose-α(1-2)-galactose (Fucα(1-2)Gal) is involved in many important physiological processes, such as learning and memory, inflammation, asthma, and tumorigenesis. However, the size and structural complexity of Fucα(1-2)Gal-containing glycans have posed a significant challenge to their detection. We report a new chemoenzymatic strategy for the rapid, sensitive detection of Fucα(1-2)Gal glycans. We demonstrate that the approach is highly selective for the Fucα(1-2)Gal motif, detects a variety of complex glycans and glycoproteins, and can be used to profile the relative abundance of the motif on live cells, discriminating malignant from normal cells. This approach represents a new potential strategy for biomarker detection and expands the technologies available for understanding the roles of this important class of carbohydrates in physiology and disease.
-
O-Glycosylation of EGF Repeats: Identification and Initial Characterization of a UDP-glucose: Protein O-glucosyltransferase
L Shao,Y Luo,DJ Moloney,RS Haltiwanger
DOI: https://doi.org/10.1093/glycob/cwf085
2002-01-01
Glycobiology
Abstract:O-Glucose is an unusual form of posttranslational modification consisting of glucose directly attached to protein through O-linkage. Several serum proteins (factor VII, factor IX, protein Z, and thrombospondin) contain this unique modification on their epidermal growth factor (EGF)-like repeats. Comparison of the glycosylation sites on these proteins revealed a putative consensus sequence for O-glucose modification: C(1)XSXPC(2), where C(1) and C(2) are the first and second conserved cysteines of the EGF repeat. We identify and characterize an enzymatic activity capable of adding glucose to EGF repeats: UDP-glucose: protein O-glucosyltransferase. Using extracts of Chinese hamster ovary cells as the enzyme source, recombinant factor VII EGF repeat as the acceptor, and UDP-[(3)H]glucose as the donor, we show that the activity is linearly dependent on time, enzyme amount, and substrate concentration. As with most glycosyltransferases, metal ions (such as manganese) are required for activity. Analysis demonstrated that the glucose is added in O-linkage to the EGF repeat. Mutation of the serine to alanine in the predicted glycosylation site abrogates glycosylation, as does reduction and alkylation of the EGF repeat, suggesting that the enzyme recognizes not only the consensus sequence but also the 3D structure of the EGF repeat. Detection of O-glucosyltransferase activity in extracts of cell lines from insects to humans and a variety of rat tissues suggests that O-glucose modification is widespread in biology. These studies lay the foundation for future work on the biological role of the O-glucose modification.
-
Notch Ligands Are Substrates for Protein O-Fucosyltransferase-1 and Fringe
VM Panin,L Shao,L Lei,DJ Moloney,KD Irvine,RS Haltiwanger
DOI: https://doi.org/10.1074/jbc.m204445200
2002-01-01
Abstract:O-Fucose has been identified on epidermal growth factor-like (EGF) repeats of Notch, and elongation of O-fucose has been implicated in the modulation of Notch signaling by Fringe. O-Fucose modifications are also predicted to occur on Notch ligands based on the presence of the C(2)XXGG(S/T)C-3 consensus site (where S/T is the modified amino acid) in a number of the EGF repeats of these proteins. Here we establish that both mammalian and Drosophila Notch ligands are modified with O-fucose glycans, demonstrating that the consensus site was useful for making predictions. The presence of O-fucose on Notch ligands raised the question of whether Fringe, an O-fucose specific beta1,3-N-acetylglucosaminyltransferase, was capable of modifying O-fucose on the ligands. Indeed, O-fucose on mammalian Deltal and Jagged1 can be elongated with Manic Fringe in vivo, and Drosophila Delta and Serrate are substrates for Drosophila Fringe in vitro. These results raise the interesting possibility that alteration of O-fucose glycans on Notch ligands could play a role in the mechanism of Fringe action on Notch signaling. As an initial step to begin addressing the role of the O-fucose glycans on Notch ligands in Notch signaling, a number of mutations in predicted O-fucose glycosylation sites on Drosophila Serrate have been generated. Interestingly, analysis of these mutants has revealed that O-fucose modifications occur on some EGF repeats not predicted by the C(2)XXGGS/TC3 consensus site. A revised, broad consensus site, (CX3-5S)-X-2/TC3 (where X3-5 are any 3-5 amino acid residues), is proposed.
-
Novel antibodies detect nucleocytoplasmic O-fucose in protist pathogens, cellular slime molds, and plants
Megna Tiwari,Elisabet Gas-Pascual,Manish Goyal,Marla Popov,Kenjiroo Matsumoto,Marianne Grafe,Ralph Graf,Robert S Haltiwanger,Neil E Olszewski,Ron Orlando,John Samuelson,Christopher M West
DOI: https://doi.org/10.1101/2024.10.15.618526
2024-10-22
Abstract:Cellular adaptations to change often involve post-translational modifications of nuclear and cytoplasmic proteins. An example found in protists and plants is the modification of serine and threonine residues of dozens to hundreds of nucleocytoplasmic proteins with a single fucose (O-Fuc). A nucleocytoplasmic O-fucosyltransferase (OFT) occurs in the pathogen Toxoplasma gondii, the social amoeba Dictyostelium, and higher plants, where it is called Spy because mutants have a spindly appearance. O-fucosylation, which is required for optimal proliferation of Toxoplasma and Dictyostelium, is paralogous to the O-GlcNAcylation of nucleocytoplasmic proteins of plants and animals that is involved in stress and nutritional responses. O-Fuc was first discovered in Toxoplasma using Aleuria aurantia lectin, but its broad specificity for terminal fucose residues on N- and O-linked glycans in the secretory pathway limits its use. Here we present affinity purified rabbit antisera that are selective for the detection and enrichment of proteins bearing fucose-O-Ser or fucose-O-Thr. These antibodies detect numerous nucleocytoplasmic proteins in Toxoplasma, Dictyostelium, and Arabidopsis, as well as O-Fuc occurring on secretory proteins of mammalian and Dictyostelium cells, although the latter are sometimes capped by further glycosylation. The antibodies label Toxoplasma, Acanthamoeba, and Dictyostelium in a pattern reminiscent of O-GlcNAc in animal cells including nuclear pores. The O-fucome of Dictyostelium is partially conserved with that of Toxoplasma and is highly induced during starvation-induced development. These antisera demonstrate the unique antigenicity of O-Fuc, document conservation of the O-fucome among unrelated protists, and will enable the study of the O-fucomes of other organisms possessing OFT-like genes.
Cell Biology
-
Appropriate aglycone modification significantly expands the glycan substrate acceptability of α1,6-fucosyltransferase (FUT8)
Roushu Zhang,Qiang Yang,Bhargavi M Boruah,Guanghui Zong,Chao Li,Digantkumar Chapla,Jeong-Yeh Yang,Kelley W Moremen,Lai-Xi Wang
DOI: https://doi.org/10.1042/BCJ20210138
2021-04-30
Abstract:The α1,6-fucosyltransferase, FUT8, is the sole enzyme catalyzing the core-fucosylation of N-glycoproteins in mammalian systems. Previous studies using free N-glycans as acceptor substrates indicated that a terminal β1,2-GlcNAc moiety on the Man-α1,3-Man arm of N-glycan substrates is required for efficient FUT8-catalyzed core-fucosylation. In contrast, we recently demonstrated that, in a proper protein context, FUT8 could also fucosylate Man5GlcNAc2 without a GlcNAc at the non-reducing end. We describe here a further study of the substrate specificity of FUT8 using a range of N-glycans containing different aglycones. We found that FUT8 could fucosylate most of high-mannose and complex-type N-glycans, including highly branched N-glycans from chicken ovalbumin, when the aglycone moiety is modified with a 9-fluorenylmethyloxycarbonyl (Fmoc) moiety or in a suitable peptide/protein context, even if they lack the terminal GlcNAc moiety on the Man-α1,3-Man arm. FUT8 could also fucosylate paucimannose structures when they are on glycoprotein substrates. Such core-fucosylated paucimannosylation is a prominent feature of lysosomal proteins of human neutrophils and several types of cancers. We also found that sialylation of N-glycans significantly reduced their activity as a substrate of FUT8. Kinetic analysis demonstrated that Fmoc aglycone modification could either improve the turnover rate or decrease the KM value depending on the nature of the substrates, thus significantly enhancing the overall efficiency of FUT8 catalyzed fucosylation. Our results indicate that an appropriate aglycone context of N-glycans could significantly broaden the acceptor substrate specificity of FUT8 beyond what has previously been thought.
-
Characterizing human α-1,6-fucosyltransferase (FUT8) substrate specificity and structural similarities with related fucosyltransferases
Bhargavi M Boruah,Renuka Kadirvelraj,Lin Liu,Annapoorani Ramiah,Chao Li,Guanghui Zong,Gerlof P Bosman,Jeong-Yeh Yang,Lai-Xi Wang,Geert-Jan Boons,Zachary A Wood,Kelley W Moremen,Bhargavi M. Boruah,Gerlof P. Bosman,Zachary A. Wood,Kelley W. Moremen
DOI: https://doi.org/10.1074/jbc.ra120.014625
IF: 5.485
2020-12-01
Journal of Biological Chemistry
Abstract:Mammalian Asn-linked glycans are extensively processed as they transit the secretory pathway to generate diverse glycans on cell surface and secreted glycoproteins. Additional modification of the glycan core by α-1,6-fucose addition to the innermost GlcNAc residue (core fucosylation) is catalyzed by an α-1,6-fucosyltransferase (FUT8). The importance of core fucosylation can be seen in the complex pathological phenotypes of FUT8 null mice, which display defects in cellular signaling, development, and subsequent neonatal lethality. Elevated core fucosylation has also been identified in several human cancers. However, the structural basis for FUT8 substrate specificity remains unknown.Here, using various crystal structures of FUT8 in complex with a donor substrate analog, and with four distinct glycan acceptors, we identify the molecular basis for FUT8 specificity and activity. The ordering of three active site loops corresponds to an increased occupancy for bound GDP, suggesting an induced-fit folding of the donor-binding subsite. Structures of the various acceptor complexes were compared with kinetic data on FUT8 active site mutants and with specificity data from a library of glycan acceptors to reveal how binding site complementarity and steric hindrance can tune substrate affinity. The FUT8 structure was also compared with other known fucosyltransferases to identify conserved and divergent structural features for donor and acceptor recognition and catalysis. These data provide insights into the evolution of modular templates for donor and acceptor recognition among GT-B fold glycosyltransferases in the synthesis of diverse glycan structures in biological systems.
biochemistry & molecular biology
-
Fringe Modifies O-fucose on Mouse Notch1 at Epidermal Growth Factor-Like Repeats Within the Ligand-Binding Site and the Abruptex Region.
L Shao,DJ Moloney,R Haltiwanger
DOI: https://doi.org/10.1074/jbc.m212221200
2003-01-01
Abstract:Fringe plays a key role in the specification of boundaries during development by modulating the ability of Notch ligands to activate Notch receptors. Fringe is a fucose-specific β1,3-N-acetylglucosaminyltransferase that modifiesO-fucose moieties on the epidermal growth factor-like (EGF) repeats of Notch. To investigate how the change in sugar structure caused by Fringe modulates Notch activity, we have analyzed the sites of O-fucose and Fringe modification on mouse Notch1. The extracellular domain of Notch1 has 36 tandem EGF repeats, many of which are predicted to be modified with O-fucose. We recently proposed a broadened consensus sequence forO-fucose, C2 X 3–5(S/T)C3(where C2 and C3 represent the second and third conserved cysteines), significantly expanding the potential number of modification sites on Notch. Here we demonstrate that sites predicted using this broader consensus sequence are modified withO-fucose on mouse Notch1, and we present evidence suggesting that the consensus can be further refined to C2 X 4–5(S/T)C3. In particular, we demonstrate that EGF 12, a portion of the ligand-binding site, is modified with O-fucose and that this site is evolutionarily conserved. We also show that endogenous Fringe proteins in Chinese hamster ovary cells (Lunatic fringe and Radical fringe) as well as exogenous Manic fringe modifyO-fucose on many but not all EGF repeats of mouse Notch1. These findings suggest that the Fringes show a preference forO-fucose on some EGF repeats relative to others. This specificity appears to be encoded within the amino acid sequence of the individual EGF repeats. Interestingly, our results reveal that Manic fringe modifies O-fucose both at the ligand-binding site (EGF 12) and in the Abruptex region. These findings provide insight into potential mechanisms by which Fringe action on Notch receptors may influence both the affinity of Notch-ligand binding and cell-autonomous inhibition of Notch signaling by ligand.
-
Fucosylation of chitooligosaccharides by human alpha1,6-fucosyltransferase requires a nonreducing terminal chitotriose unit as a minimal structure
Hideyuki Ihara,Shinya Hanashima,Takahiro Okada,Ritsu Ito,Yoshiki Yamaguchi,Naoyuki Taniguchi,Yoshitaka Ikeda
DOI: https://doi.org/10.1093/glycob/cwq064
Glycobiology
Abstract:FUT8, a eukaryotic alpha1,6-fucosyltransferase, catalyzes the transfer of a fucosyl residue from guanine nucleotide diphosphate-beta-l-fucose to the innermost GlcNAc of an asparagine-linked oligosaccharide (N-glycan). The catalytic domain of FUT8 is structurally similar to that of NodZ, a bacterial alpha1,6-fucosyltransferase, which acts on a chitooligosaccharide in the synthesis of Nod factor. While the substrate specificities for the nucleotide sugar and the N-glycan have been determined, it is not known whether FUT8 is able to fucosylate other sugar chains such as chitooligosaccharides. The present study was conducted to investigate the action of FUT8 on chitooligosaccharides that are not generally thought to be a substrate in mammals, and the results indicate that FUT8 is able to fucosylate such structures in a manner comparable to NodZ. Surprisingly, structural analyses of the fucosylated products by high performance liquid chromatography, mass spectrometry and nuclear magnetic resonance indicated that FUT8 does not utilize the reducing terminal GlcNAc for fucose transfer but shows a preference for the third GlcNAc residue from the nonreducing terminus of the acceptor. These findings suggest that FUT8 catalyzes the fucosylation of chitooligosaccharide analogous to NodZ, but that a nonreducing terminal chitotriose structure is required for the reaction. The substrate recognition by which FUT8 selects the position to fucosylate might be distinct from that for NodZ and could be due to structural factor requirements which are inherent in FUT8.
-
O-fucose monosaccharide of Drosophila Notch has a temperature-sensitive function and cooperates with O-glucose glycan in Notch transport and Notch signaling activation
Akira Ishio,Takeshi Sasamura,Tomonori Ayukawa,Junpei Kuroda,Hiroyuki O Ishikawa,Naoki Aoyama,Kenjiroo Matsumoto,Takuma Gushiken,Tetsuya Okajima,Tomoko Yamakawa,Kenji Matsuno
DOI: https://doi.org/10.1074/jbc.M114.616847
2015-01-02
Abstract:Notch (N) is a transmembrane receptor that mediates the cell-cell interactions necessary for many cell fate decisions. N has many epidermal growth factor-like repeats that are O-fucosylated by the protein O-fucosyltransferase 1 (O-Fut1), and the O-fut1 gene is essential for N signaling. However, the role of the monosaccharide O-fucose on N is unclear, because O-Fut1 also appears to have O-fucosyltransferase activity-independent functions, including as an N-specific chaperon. Such an enzymatic activity-independent function could account for the essential role of O-fut1 in N signaling. To evaluate the role of the monosaccharide O-fucose modification in N signaling, here we generated a knock-in mutant of O-fut1 (O-fut1(R245A knock-in)), which expresses a mutant protein that lacks O-fucosyltransferase activity but maintains the N-specific chaperon activity. Using O-fut1(R245A knock-in) and other gene mutations that abolish the O-fucosylation of N, we found that the monosaccharide O-fucose modification of N has a temperature-sensitive function that is essential for N signaling. The O-fucose monosaccharide and O-glucose glycan modification, catalyzed by Rumi, function redundantly in the activation of N signaling. We also showed that the redundant function of these two modifications is responsible for the presence of N at the cell surface. Our findings elucidate how different forms of glycosylation on a protein can influence the protein's functions.
-
Roles of Pofut1 and O-fucose in Mammalian Notch Signaling.
Pamela Stanley,Changhui Ge,Mark Stahl,Kazuhide Uemura,Shaolin Shi
DOI: https://doi.org/10.1074/jbc.m802027200
2008-01-01
Abstract:Mammalian Notch receptors contain 29-36 epidermal growth factor (EGF)-like repeats that may be modified by protein O-fucosyltransferase 1 (Pofut1), an essential component of the canonical Notch signaling pathway. The Drosophila orthologue Ofut1 is proposed to function as both a chaperone required for stable cell surface expression of Notch and a protein O-fucosyltransferase. Here we investigate these dual roles of Pofut1 in relation to endogenous Notch receptors of Chinese hamster ovary and murine embryonic stem (ES) cells. We show that fucosylation-deficient Lec13 Chinese hamster ovary cells have wild type levels of Pofut1 and cell surface Notch receptors. Nevertheless, they have reduced binding of Notch ligands and low levels of Delta1- and Jagged1-induced Notch signaling. Exogenous fucose but not galactose rescues both ligand binding and Notch signaling. Murine ES cells lacking Pofut1 also have wild type levels of cell surface Notch receptors. However, Pofut1-/- ES cells do not bind Notch ligands or exhibit Notch signaling. Although overexpression of fucosyltransferase-defective Pofut1 R245A in Pofut1-/- cells partially rescues ligand binding and Notch signaling, this effect is not specific. The same rescue is achieved by an unrelated, inactive, endoplasmic reticulum glucosidase. Therefore, mammalian Notch receptors require Pofut1 for the generation of optimally functional Notch receptors, but, in contrast to Drosophila, Pofut1 is not required for stable cell surface expression of Notch. Importantly, we also show that, under certain circumstances, mammalian Notch receptors are capable of signaling in the absence of Pofut1 and O-fucose.
-
NATALIA NAPPI PERRELLA METABOLISM OF FUCOSE, ALPHA-L-FUCOSIDASES AND FUCOSYLTRANSFERASES: ENZYMATIC CHARACTERISATION, MECHANISM OF CATALYSIS AND PHYSIOLOGICAL ROLE
A. Lopes
Abstract:Perrella NN. Metabolism of fucose, alpha-L-fucosidases, and fucosyltransferases: Enzymatic characterisation, mechanism of catalysis and physiological role. [Ph. D. thesis (Biotechnology)]. São Paulo: Instituto de Ciências Biomédicas, Universidade de São Paulo, 2018. Carbohydrates are diverse and complex molecules being employed by living organisms in biological functions such as energetic, structural and signalling events. L-Fucose is a monosaccharide component of many glycans present in a variety of biological groups, such as mammals, insects, and plants. Some of the best-known examples of post-translational modified molecules containing L-Fucose are the ABO blood antigen system and human milk. Changes in the fucosylation pattern are related to pathologies like cancer and fucosidosis. These changes are related to the balance between the activities of α-L-fucosidases and fucosyltransferases. α-Lfucosidases are glycoside hydrolases that catalyse the hydrolysis of glycosidic bonds between residues of L-Fucose to other molecules. Fucosyltransferases are glycosyltransferases which transfer L-Fucose from a GDP-fucose to a specific acceptor. Although the importance of fucose metabolism, there is few information about this subject in Arthropoda. Literature indicates that fucose, α-L-fucosidases and fucosyltransferases are involved in host-pathogen interaction in ticks, suggesting that fucose metabolism is essential to Arachnida. Our aim was to study the metabolism of fucose in two Arachnida species: the spider Nephilingis cruentata and the tick Amblyomma sculptum. This was accomplished through the characterisation of native and recombinant fucosidases, structure and in silico analyses, site-directed mutagenesis, expression pattern, specificity and, effect on tumour cells. Besides that, we analysed fucosyltransferases sequences and expression by qPCR. The enzymes involved in fucose metabolic pathways were also investigated. NcFuc and AsFuc have a pH optimum of 5.0, are inhibited by fucose and fuconojirimycin and present an oligomerisation process pH dependent. We successfully produced the recombinant form of these enzymes, and they have the same kinetic properties of native forms. Natural substrate hydrolysis by NcFucr and AsFucr suggest different specificities and they were able to remove fucose residues from tumour cell lines, reducing cell invasion. Moreover, they catalysed transfucosylation reactions. The recombinant production allowed the identification of the residues D214 and E59 as the catalytic dyad in NcFuc. Phylogenetic analysis, kinetic data, molecular modelling, and specificity assays suggest that α-L-fucosidase active sites are different to each Arachnida species and indicated that the physiological significance of fucose removal is different among organisms. qPCR assays evidenced that although fucosidases might be lysosomal enzymes, they are mainly expressed at the digestive system in Arachnida and are involved in digestion. Representatives of all known families of fucosyltransferases were identified in the spider MG transcriptome data. However, POFUT1 was also identified at the proteomic level and its expression analysis indicated a higher expression at MG. This might be related to the regeneration of cells after secretion of digestive enzymes. Transcriptomic and proteomic analysis indicate that Arachnida uses both salvage and de novo pathways to fucose synthesis. Considering all the obtained data we concluded that fucose metabolism is related to digestion in Arachnida since they are able to salvage fucose from diet due to the presence of very active α-L-fucosidases.
Chemistry,Biology
-
Exploring the diverse biological significance and roles of fucosylated oligosaccharides
Burcu Pekdemir,Sercan Karav
DOI: https://doi.org/10.3389/fmolb.2024.1403727
IF: 6.113
2024-05-28
Frontiers in Molecular Biosciences
Abstract:Long since, carbohydrates were thought to be used just as an energy source and structural material. However, in recent years, with the emergence of the field of glycobiology and advances in glycomics, much has been learned about the biological role of oligosaccharides, a carbohydrate polymer containing a small number of monosaccharides, in cell–cell interaction, signal transduction, immune response, pathogen adhesion processes, early embryogenesis, and apoptosis. The function of oligosaccharides in these processes is diversified by fucosylation, also known as modification of oligosaccharides. Fucosylation has allowed the identification of more than 100 different oligosaccharide structures that provide functional diversity. ABO blood group and Lewis antigens are among the best known fucosyl-linked oligosaccharides. In addition, the antigens in the ABO system are composed of various sugar molecules, including fucosylated oligosaccharides, and Lewis antigens are structurally similar to ABO antigens but differ in the linkage of sugars. Variation in blood group antigen expression affects the host's susceptibility to many infections. However, altered expression of ABO and Lewis antigens is related with prognosis in carcinoma types. In addition, many pathogens recognize and bind to human tissues using a protein receptor with high affinity for the fucose molecule in glycoconjugates, such as lectin. Fucosylated oligosaccharides also play vital roles during fertilization and early embryogenesis. Learning and memory-related processes such as neurite growth, neurite migration, and synapse formation seen during the development of the brain, which is among the first organs to develop in embryogenesis, are regulated by fucosylated oligosaccharides. In conclusion, this review mentions the vital roles of fucosylated oligosaccharides in biology, drawing attention to their importance in the development of chemical tools to be used in function analysis and the investigation of various therapeutic targets.
biochemistry & molecular biology
-
Novel forms of protein glycosylation
J F Vliegenthart,F Casset
DOI: https://doi.org/10.1016/s0959-440x(98)80145-0
Abstract:A large number of new glycans, derived from glycoproteins, has been characterized in the past few years. O-linked fucose was found in epidermal growth factor-like domains of several proteins. For the N-linked glycans of Helix pomatia hemocyanin, novel types of antennae were identified. The positions of noncarbohydrate substituents were established in N-glycans. C-mannosylation of a tryptophan residue was discovered in human ribonuclease 2 and is the first example of C-glycosylation in glycoproteins.
-
Structure of a Novel O-Linked N-Acetyl-d-glucosamine (O-Glcnac) Transferase, GtfA, Reveals Insights into the Glycosylation of Pneumococcal Serine-rich Repeat Adhesins
Wei-Wei Shi,Yong-Liang Jiang,Fan Zhu,Yi-Hu Yang,Qiu-Yan Shao,Hong-Bo Yang,Yan-Min Ren,Hui Wu,Yuxing Chen,Cong-Zhao Zhou
DOI: https://doi.org/10.1074/jbc.m114.581934
IF: 5.485
2014-01-01
Journal of Biological Chemistry
Abstract:Protein glycosylation catalyzed by the O-GlcNAc transferase (OGT) plays a critical role in various biological processes. In Streptococcus pneumoniae, the core enzyme GtfA and co-activator GtfB form an OGT complex to glycosylate the serine-rich repeat (SRR) of adhesin PsrP (pneumococcal serine-rich repeat protein), which is involved in the infection and pathogenesis. Here we report the 2.0 angstrom crystal structure of GtfA, revealing a beta-meander add-on domain beyond the catalytic domain. It represents a novel add-on domain, which is distinct from the all alpha-tetratricopeptide repeats in the only two structure-known OGTs. Structural analyses combined with binding assays indicate that this add-on domain contributes to forming an active GtfA-GtfB complex and recognizing the acceptor protein. In addition, the in vitro glycosylation system enables us to map the O-linkages to the serine residues within the first SRR of PsrP. These findings suggest that fusion with an add-on domain might be a universal mechanism for diverse OGTs that recognize varying acceptor proteins/peptides.
-
Targeted Fucosylation of Glycans with Engineered Bacterial Fucosyltransferase Variants
Viktoria Heine,Helena Pelantová,Pavla Bojarová,Vladimír Křen,Lothar Elling
DOI: https://doi.org/10.1002/cctc.202200037
IF: 4.5
2022-02-15
ChemCatChem
Abstract:Fucosyltransferases (FucTs) are crucial for the synthesis of Lewis-type glycan epitopes. The synthetic capacity of efficient bacterial enzymes and their variants has not yet been fully exploited. In the present work, we investigated two previously described variants of α1,3FucT from Helicobacter pylori strains for their flexibility in substrate utilization and their applicability in the enzymatic synthesis of Lewis epitopes. We used the truncated enzyme variant of FutA from H. pylori 26695 (FucTΔ52 A128N/H129E/Y132I/S46F, FucTΔ52-4M) and the truncated α3FucT from H. pylori NCTC11639 (FucTΔ66). N -Acetyllactosamine type 1 and type 2 as well as N',N'' -diacetyllactosamine were investigated as substrates. Both FucT variants exhibit α1,3/4FucT activity. Novel glycan structures were obtained displaying Lewis blood group antigens in a site-specific sequence. Fucosylated N',N'' -diacetyllactosamine was synthesized for the first time with FucTΔ52-4M. Our work paves the way for targeted fucosylation patterns that can be tested for lectin binding.
chemistry, physical
-
Protein oxidation of fucose environments (POFE) reveals fucose-protein interactions
Yixuan Xie,Siyu Chen,Michael Russelle Alvarez,Ying Sheng,Qiongyu Li,Emanual Maverakis,Carlito B Lebrilla
DOI: https://doi.org/10.1039/d3sc06432h
2024-03-11
Abstract:Cell membrane glycoproteins are generally highly fucosylated and sialylated, and post-translational modifications play important roles in the proteins' functions of signaling, binding and cellular processing. For these reasons, methods for measuring sialic acid-mediated protein-protein interactions have been developed. However, determining the role of fucose in these interactions has been limited by technological barriers that have thus far hindered the ability to characterize and observe fucose-mediated protein-protein interactions. Herein, we describe a method to metabolically label mammalian cells with modified fucose, which incorporates a bioorthogonal group into cell membrane glycoproteins thereby enabling the characterization of cell-surface fucose interactome. Copper-catalyzed click chemistry was used to conjugate a proximity labeling probe, azido-FeBABE. Following the addition of hydrogen peroxide (H2O2), the fucose-azido-FeBABE catalyzed the formation of hydroxyl radicals, which in turn oxidized the amino acids in the proximity of the labeled fucose residue. The oxidized peptides were identified using liquid chromatography coupled with tandem mass spectrometry (LC-MS/MS). Variations in degree of protein oxidation were obtained with different H2O2 reaction times yielding the acquisition of spatial information of the fucose-interacting proteins. In addition, specific glycoprotein-protein interactions were constructed for Galectin-3 (LEG3) and Galectin-3-binding protein (LG3BP) illustrating the further utility of the method. This method identifies new fucose binding partners thereby enhancing our understanding of the cell glycocalyx.
-
Ancestral exonic organization of FUT8, the gene encoding the alpha6-fucosyltransferase, reveals successive peptide domains which suggest a particular three-dimensional core structure for the alpha6-fucosyltransferase family
C Javaud,F Dupuy,A Maftah,J C Michalski,R Oriol,J M Petit,R Julien
DOI: https://doi.org/10.1093/oxfordjournals.molbev.a026265
Abstract:Based on PCR strategies and expression studies, we define the genomic organization of the FUT8b gene. This gene encodes the only known mammalian enzyme transferring fucose in an alpha1-->6 linkage on the asparagine-branched GlcNAc residue of the chitobiose unit of complex N:-glycans. The intron/exon organization of the bovine coding sequence determines five successive functional domains. The first exon encodes a domain homologous to cytoskeleton proteins, the second presents a proline-rich region including a motif XPXPPYXP similar to the peptide ligand of the SH3-domain proteins, the third encodes a gyrase-like domain (an enzyme which can bind nucleotides), and the fourth encodes a peptide sequence homologous to the catalytic domain of proteins transferring sugars. Finally, the last exon encodes a domain homologous to the SH3 conserved motif of the SH2-SH3 protein family. This organization suggests that intramolecular interactions might give a tulip-shaped scaffolding, including the catalytic pocket of the enzyme in the Golgi lumen. Deduced from the published sequence of chromosome 14 (AL109847), the human gene organization of FUT8 seems to be similar to that of bovine FUT8b, although the exon partition is more pronounced (bovine exons 1 and 2 correspond to human exons 1-6). The mosaicism and phylogenetic positions of the alpha6-fucosyltransferase genes are compared with those of other fucosyltransferase genes.
-
Analysis of endogenous NOTCH1 from patient fibroblasts reveals the importance of the -fucose modification on EGF12 in human development
Kenjiroo Matsumoto,Kelvin B. Luther,Robert S. Haltiwanger
DOI: https://doi.org/10.1101/2024.04.09.588484
2024-04-09
Abstract:NOTCH1 (N1) is a transmembrane receptor interacting with membrane-tethered ligands on opposing cells that mediate the direct cell-cell interaction necessary for many cell fate decisions. Protein -fucosyltransferase 1 (POFUT1) adds -fucose to Epidermal Growth Factor (EGF)-like repeats in the NOTCH1 extracellular domain, which is required for trafficking and signaling activation. We previously showed that caused a 90% loss of POFUT1 activity and global developmental defects in a patient; however, the mechanism by which POFUT1 contributes to these symptoms is still unclear. Compared to controls, patient fibroblast cells had an equivalent amount of N1 on the cell surface but showed a 60% reduction of DLL1 ligand binding and a 70% reduction in JAG1 ligand binding. To determine if the reduction of -fucose on N1 in patient fibroblasts was the cause of these effects, we immunopurified endogenous N1 from control and patient fibroblasts and analyzed -fucosylation using mass spectral glycoproteomics methods. N1 EGF8 to EGF12 comprise the ligand binding domain, and -fucose on EGF8 and EGF12 physically interact with ligands to enhance affinity. Glycoproteomics of N1 from patient fibroblasts showed WT fucosylation levels at all sites analyzed except for a large decrease at EGF9 and the complete absence of -fucose at EGF12. Since the loss of -fucose on EGF12 is known to have significant effects on N1 activity, this may explain the symptoms observed in the patient.
Biochemistry
-
O-Fucosylation of Muscle Agrin Determines Its Ability to Cluster Acetylcholine Receptors
Mi-Lyang Kim,Kumaran Chandrasekharan,Matthew Glass,Shaolin Shi,Mark C. Stahl,Brian Kaspar,Pamela Stanley,Paul T. Martin
DOI: https://doi.org/10.1016/j.mcn.2008.07.026
2008-01-01
Molecular and Cellular Neurosciences
Abstract:Protein O-fucosyltransferase 1 (Pofut1) transfers fucose to serine or threonine on proteins, including Notch receptors, that contain EGF repeats with a particular consensus sequence. Here we demonstrate that agrin is O-fucosylated in a Pofut1-dependent manner, and that this glycosylation can regulate agrin function. Fucosylation of recombinant C45 agrin, both active (neural, z8) and inactive (muscle, z0) splice forms, was eliminated when agrin was overexpressed in Pofut1-deficient cells or by mutation of a consensus site for Pofut1 fucosylation (serine 1726 in the EGF4 domain). Loss of O-fucosylation caused a gain of function for muscle agrin such that it stimulated AChR clustering and MuSK phosphorylation in cultured myotubes at levels normally only found with the neural splice form. Deletion of Pofut1 in cultured primary myotubes and in adult skeletal muscle increased AChR aggregation. In addition, Pofut1 gene and protein expression and Pofut1 activity of the EGF4 domain of agrin were modulated during neuromuscular development. These data are consistent with a role for Pofut1 in AChR aggregation during synaptogenesis via the regulation of the synaptogenic activity of muscle agrin.
-
Fucosidases from the human gut symbiont Ruminococcus gnavus
Haiyang Wu,Osmond Rebello,Emmanuelle H. Crost,C. David Owen,Samuel Walpole,Chloe Bennati-Granier,Didier Ndeh,Serena Monaco,Thomas Hicks,Anna Colvile,Paulina A. Urbanowicz,Martin A. Walsh,Jesus Angulo,Daniel I. R. Spencer,Nathalie Juge
DOI: https://doi.org/10.1007/s00018-020-03514-x
IF: 8
2020-04-24
Cellular and Molecular Life Sciences
Abstract:Abstract The availability and repartition of fucosylated glycans within the gastrointestinal tract contributes to the adaptation of gut bacteria species to ecological niches. To access this source of nutrients, gut bacteria encode α- l -fucosidases (fucosidases) which catalyze the hydrolysis of terminal α- l -fucosidic linkages. We determined the substrate and linkage specificities of fucosidases from the human gut symbiont Ruminococcus gnavus . Sequence similarity network identified strain-specific fucosidases in R. gnavus ATCC 29149 and E1 strains that were further validated enzymatically against a range of defined oligosaccharides and glycoconjugates. Using a combination of glycan microarrays, mass spectrometry, isothermal titration calorimetry, crystallographic and saturation transfer difference NMR approaches, we identified a fucosidase with the capacity to recognize sialic acid-terminated fucosylated glycans (sialyl Lewis X/A epitopes) and hydrolyze α1–3/4 fucosyl linkages in these substrates without the need to remove sialic acid. Molecular dynamics simulation and docking showed that 3′-Sialyl Lewis X (sLeX) could be accommodated within the binding site of the enzyme. This specificity may contribute to the adaptation of R. gnavus strains to the infant and adult gut and has potential applications in diagnostic glycomic assays for diabetes and certain cancers.
cell biology,biochemistry & molecular biology